[Other] First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

tarekcnn Post time Yesterday 23:36 | Show all posts |Read mode
This post will be closed automatically in 2026-07-27 23:36
Reward20points

journalㄩJournal of Clinical Oncology

AuthorsㄩHeinz-Josef Lenz; Eric Van Cutsem; Maria Luisa Limon; Ka Yeung Mark Wong; Alain Hendlisz; Massimo Aglietta; Pilar Garc赤a-Alfonso; Bart Neyns; Gabriele Luppi; Dana B. Cardin; Tomislav Dragovich; Usman Shah; Sandzhar Abdullaev; Joseph Gricar; Jean-Marie Ledeine; Michael James Overman; Sara Lonardi

Published dateㄩ2022-1-10

DOIㄩ10.1200/jco.21.01015

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01015

Article linkㄩhttps://doi.org/10.1200/jco.21.01015

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
Victor91 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    330

Return to the list